Eric Lefkofsky is by car one of the most interesting people I have ever stumbled across during a lazy Sunday morning of internet browsing. I came upon a news article about his most recent venture, Tempus, a startup in the healthcare sector that is revolutionizing how physicians put together cancer treatment plans.
Tempus itself is just as fascinating as founder Eric Lefkofsky. The company has lofty goals with the main one being to improve patient outcomes for people with cancer. They are on a mission to redefine the way that human genome data can be used in a clinical setting.
They are seeking to build the largest library of clinical and molecular data in the world and then make that digital operatin system open and available to physicians. By having this data collected in one place, physicians and oncologists will be able to provide extremely custom cancer treatment plans for their patients based upon data driven technology.
First of all, when talking about Eric Lefkofsky’s business success in the technology and startup sectors, let’s just put it out there that he founded Groupon. Groupon. While that’s not the focus of this article, the next time you want 20% off of a hair cut, a discounted massage or to grab two for one entrees at a new local restaurant, you can thank Eric.
Similarly, hopefully years from now the next time a physician and their team accesses a full system of harvested genome and cancer treatment data and puts together a fully custom cancer treatment plan for their patient, they can think of Eric Lefkofsky.
Tempus recently made a huge announcement. The company has opened up for a Series C funding round and raised an additional $70 million in funds to support the company’s already rapid growth. This comes in addition to the first two rounds and totals over $130 million in funding bringing Tempuses estimated valuation to $700 million.
Eric Lefkofsky and his partner have both personally donated to each round of funding and Eric is so confident in Tempuses future success that he even stated he would invest up to $100 million of his personal funds to the company.